This site is intended for Healthcare professionals only.

RNS System-New treatment option for seizure control in refractory epilepsy


RNS System-New treatment option for seizure control in refractory epilepsy

For patients of Refractory Epilepsy not responding to medication who had to resort to surgery earlier have a new option in  RNS System for seizure control.

A 27-year-old man, Richard Pollitt got relief from his continuously bothering seizures that sometimes lasted for five minutes through implantation of a small battery-powered device in his skull. Now, he rarely gets those seizures.

Patients are diagnosed with refractory epilepsy when seizures do not respond to medication. For such patients, the next treatment option is surgery to remove the brain area causing the seizures. However, patients whose seizures originate on both sides of the brain are typically not candidates for this surgical option.

“Traditional surgery wasn’t an option for Richard because removing tissue from both sides of the brain would have left him with no memory,” said Amit Verma, M.D., a Houston Methodist neurologist who specializes in epilepsy and seizures. “After considering a range of options, we decided that Richard would be a good candidate for a device that can help stop seizures from both regions of the brain.”

Read Also: Deep Brain Stimulation approved for Refractory Epilepsy

Responsive neurostimulation device or the RNS System treats patients with refractory epilepsy by continually observing and recording brain activity, recognizing abnormal signals, and producing small electrical pulses to stabilize brain activity and help stop seizures before physical symptoms appear. Developed by Neuropace, the system consists of a neurostimulator that is implanted into the skull and a remote that allows patients to wirelessly collect information for their physician. Once the device is turned on, it logs valuable data that allows physicians to track a patient’s treatment and improve care.

“The data from the device shows that Richard has had only three seizures since the surgery in January,” Verma said. “That’s close to a 95 percent reduction rate in seizures, which is a remarkable improvement.”

Pollitt’s mother, Peggy, said the surgery has given her son a fresh start in life and provided peace of mind to his family.

“The device is so discreet that he can’t feel it,” Peggy said. “His medication doses have been reduced, he’s experienced increased energy levels and improved memory and clarity, and he rarely has seizures now. Any seizures he does have don’t last as long and aren’t nearly as severe as before.”

Verma said there are very few patients, if any, who become completely seizure free with the RNS System. However, it has been proven an effective treatment in clinical studies as patients experienced a significant reduction rate in seizures that continued to improve over time.

The device’s battery needs to be replaced every three to five years.

The following two tabs change content below.
Medha Baranwal

Medha Baranwal

Medha Baranwal joined Medical Dialogues as a Desk Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She can be contacted at medha@medicaldialogues.in. Contact no. 011-43720751
Source: press release

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted